Weightlifter Suspended After Testosterone Violation
A U.S. weightlifter received a one-year suspension after testing positive for a prohibited substance.
Updated on Sept. 26, 2026 in Body Building
Live Poll
Should anti-doping agencies reduce athlete suspensions when a physician authorized the prohibited substance use?
The U.S. Anti-Doping Agency suspended weightlifter Seth Lingafeldt for one year following a positive test for exogenous testosterone. The sanction, which began on May 14, 2026, followed the disqualification of all competitive results achieved by the athlete since November 21, 2025.
Why it matters
This case highlights the strict regulatory requirements for hormone therapy, as the athlete's failure to secure a Therapeutic Use Exemption for physician-directed treatment led to a violation. It underscores why athletes must navigate official exemptions even when using substances under clinical supervision.
A urine sample collected on April 12, 2026, and analyzed via Isotope Ratio Mass Spectrometry confirmed the presence of exogenous testosterone. USADA reduced the standard four-year sanction to one year, citing the athlete's documented due diligence and physician-directed use.
The players
Seth Lingafeldt
A weightlifter who competed at the Masters Nationals and was suspended for a doping violation.
U.S. Anti-Doping Agency
The independent national organization responsible for managing testing and education programs in the United States.
The details
Isotope Ratio Mass Spectrometry is a highly sensitive analytical technique used by labs to distinguish between testosterone naturally produced by the human body and testosterone introduced from external sources. Despite the athlete following a physician's directions, the lack of an approved Therapeutic Use Exemption (TUE) meant the presence of the substance violated anti-doping protocols. Consequently, all results from competitions, including the 2026 Masters Nationals, were disqualified.
Timeline
November 21, 2025: Athlete began using the prohibited substance.
April 12, 2026: Athlete provided a urine sample at Masters Nationals.
May 14, 2026: The one-year suspension period officially began.
September 24, 2026: USADA publicly announced the sanction.
May 14, 2027: The suspension period concludes.
Health Landscape
This development highlights the intersection of medical necessity and the rigorous regulatory framework governing competitive sport. It reflects the broader requirement that all medical interventions involving prohibited substances must receive prior authorization through established regulatory pathways.
This case underscores the importance of discussing a sport's prohibited substance list with both your physician and your governing body before beginning any new treatment. Even when a treatment is medically indicated, managing the compliance process is essential for athletes subject to testing.
The takeaway
The primary insight is that physician-directed treatment does not automatically grant exemption from anti-doping policies in competitive sports. Athletes should confirm the regulatory status of all prescribed medications through official anti-doping channels before initiating treatment.
Further reading
For more on training and competition safety, visit our Body Building section.
Source note: This article includes information reported by EssentiallySports.
Live Poll
Should anti-doping agencies reduce athlete suspensions when a physician authorized the prohibited substance use?
